Clinical trial
Citicoline in the Treatment of Acute Ischemic Stroke. An International Randomized Multicenter Placebo-controlled Study
NCT00331890 is registered in ClinicalTrials.gov with Ferrer Internacional S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Citicoline in the Treatment of Acute Ischemic Stroke. An International Randomized Multicenter Placebo-controlled Study
- Lead sponsor
- Ferrer Internacional S.A.
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- October 31, 2006
- Completion date
- March 31, 2012
- Enrollment
- 2,298 (actual)
- Sites
- 65
Conditions
As the registry lists them; a condition with its own page is linked.
acute stroke, cerebral infarction